CompletedNCT02447471Nexfin PilotUpdated Jan 26, 2016

Agreement of the Nexfin™ Monitor With Non-invasive Blood Pressure Measurement

An observational study in Blood Pressure Measurement, sponsored by University of British Columbia. Completed at 1 site in Canada. Open to female participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-01-26.

Sponsored by University of British Columbia · Observational

Study type: Observational
Model: Cohort
Time perspective: Prospective
Enrollment: 10
Ages: 19 Years and older
Sex: Female

Study summary

Currently, BP is measured using an inflatable cuff wrapped around the patient's upper arm. This can be set to inflate every minute, but measurement may fail due to patient movement or shivering. Failed measurement occurs in up to 38% of patients.

This study aims to determine how the Nexfin device - which measures BP using a cuff wrapped around a finger - compares to standard BP measurement.

Read the detailed description

This study aims to determine how the Nexfin device - which measures BP using a cuff wrapped around a finger - compares to standard BP measurement.

Conditions studied

Blood Pressure Measurement

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 19 Years and older
Sexes eligible: Female
Accepts healthy volunteers: Yes
Sampling method: Non-probability sample

Study population

BC Women's hospital parturients

Inclusion criteria

Healthy female pregnant patients
≥19 years old
Undergoing elective Cesarean section under spinal or combined spinal-epidural anesthesia

Exclusion criteria

Exclusion Criteria:

Contraindication to wearing Nexfin cuff (upper limb vascular disease, amputated digits)
Obesity (BMI > 38 kg/m2)
Use of arterial line for BP measurement
Inability to read and understand English

Study design

Observational model: Cohort
Time perspective: Prospective
Enrollment: 10 participants (actual)
Patient registry: No

Groups and cohorts

study group
all participants
Device: Nexfin

Interventions

DeviceNexfin
Nexfin cuff placed on finger to measure blood pressure

What researchers measure

Primary outcomes

Nexfin bp vs NIBP
Time frame: During cesarean delivery

Study locations

1 site

BC Women's Hospital
Vancouver, British Columbia V6H 3N1, Canada

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Jan 26, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT02447471
Lead sponsor: University of British Columbia
Responsible party: Sponsor
First posted: May 18, 2015
Start date: May 2015
Primary completion: Jan 2016
Completion: Jan 2016
Last update: Jan 26, 2016

Study contacts

Vit Gunka, MD FRCPC

principal investigator · University of British Columbia

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University of British Columbia

Start the discussion